Spare Paper,
"And if people are selling then they do don't fully understand or appreciate the amount of work/effort/expertise that goes into a developing biotech company in LATE STAGE TRIALS - and they don't deserve the rewards either."
True. But there are other scenarios. If you have only a small amount of capital, you've got to figure out which share will rise soonest. Even if you love PRR, you might still want to sell to double your capital quickly elsewhere, then jump back in to PRR when it starts moving up. If you have plenty of capital, you can spread your bets and stick it out for the longer term. Decisions are much easier with plenty of capital.
it`s about time, page-22
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.020(7.41%) |
Mkt cap ! $421.8M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 29.5¢ | 27.0¢ | $1.138M | 3.985M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 63444 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 65000 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |